Abstract
Steady-state levels of oxazepam (OX), nordiazepam (ND), and diazepam (DZ) in plasma, brain tissue, cerebrospinal fluid (CSF), and intracranial microdialysis perfusate were determined in dogs dependent on 0.56, 4.5, 9, and 36 mg/kg per day of DZ. There was a linear relationship between the total plasma and brain levels of DZ, ND, and OX and the chronic dose of DZ. Levels of free benzodiazepines in plasma and CSF and levels in microdialysis perfusates from plasma and brain were significantly correlated. With increasing dependence on DZ there was progressively more free ND and OX and less free DZ in plasma, CSF, and brain. There was a correlation between several signs of precipitated abstinence and free ND in the brain interstitial fluid, whereas convulsions emerged only when free metabolites exceeded free DZ. The changes in contribution of free DZ, ND, and OX to the overall levels of benzodiazepines present in the CNS may explain differences in signs of abstinence for different levels of dependence on DZ.
References
Oct 1, 1979·Journal of Pharmaceutical Sciences·R F JohnsonG R Wilkinson
Jun 1, 1975·British Journal of Clinical Pharmacology·G TognoniG Scieghi
Jun 15, 1976·European Journal of Clinical Pharmacology·U KlotzP R Bieck
Oct 1, 1991·Drug and Alcohol Dependence·J W SloanK M Dickey
Jul 1, 1991·Pharmacology, Biochemistry, and Behavior·H C RosenbergT H Chiu
Jan 1, 1991·Psychopharmacology·E P WalaJ W Sloan
Jan 1, 1990·European Journal of Clinical Pharmacology·N R BadcockD B Frewin
Jan 1, 1990·Psychopharmacology·D J Greenblatt, V H Sethy
Nov 1, 1989·Therapeutic Drug Monitoring·D J GreenblattR I Shader
Oct 1, 1989·The Journal of Clinical Investigation·R K DubeyG R Wilkinson
May 1, 1987·The Journal of Pharmacy and Pharmacology·M GobbiS Garattini
Jan 1, 1987·Psychopharmacology·R M ArendtS M Paul
Jul 1, 1966·Journal of Pharmaceutical Sciences·J A De SilvaG Bader
Aug 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·H Boxenbaum
Mar 1, 1983·The Journal of Pharmacy and Pharmacology·L J Moschitto, D J Greenblatt
Apr 20, 1984·European Journal of Pharmacology·S E Lukas, R R Griffiths
Sep 3, 1984·European Journal of Pharmacology·H H FreyW Scheuler
Apr 1, 1980·British Journal of Clinical Pharmacology·C Hallstrom, M H Lader
Jan 1, 1980·Psychopharmacology·D J GreenblattB L Lloyd
Jan 1, 1981·British Journal of Clinical Pharmacology·D J GreenblattR I Shader
May 1, 1981·Journal of Clinical Pharmacology·M D Allen, D J Greenblatt
Jan 1, 1981·European Journal of Clinical Pharmacology·U Klotz, I Reimann
Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·M F DaviesG H Loew
Jul 1, 1994·Pharmacology, Biochemistry, and Behavior·V A Ramsey-WilliamsH C Rosenberg
Nov 1, 1993·Pharmacology, Biochemistry, and Behavior·W R MartinE P Wala